(Q44647820)

5 December 2017

title

Re: a multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma (English)

1 reference

5 December 2017

1 reference

Nicholas J Vogelzang

1

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

5 December 2017

1 reference

5 December 2017

volume

5

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

63-64

1 reference

The European mesothelioma epidemic

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970322-9

7 January 2021

A Multicenter Phase II Study of Gemcitabine and Oxaliplatin for Malignant Pleural Mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970322-9

7 January 2021

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970322-9

7 January 2021

Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970322-9

7 January 2021

Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970322-9

7 January 2021

Preclinical and clinical studies with combinations of pemetrexed and gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970322-9

7 January 2021

Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970322-9

7 January 2021

Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970322-9

7 January 2021

A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970322-9

7 January 2021

10.1016/S1525-7304(11)70322-9

Identifiers

DOI

0 references

1 reference